Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
80 hedge funds and large institutions have $199M invested in Syneron Medical Ltd in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 4 closing their positions.
400% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 4
256% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 9
23% more funds holding
Funds holding: 65 → 80 (+15)
22% more capital invested
Capital invested by funds: $163M → $199M (+$35.9M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
94% less call options, than puts
Call options by funds: $84K | Put options by funds: $1.39M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$5.53M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.29M |
| 3 |
KCP
Kenmare Capital Partners
New York
|
+$2.11M |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.93M |
| 5 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
+$1.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$2.75M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.31M |
| 3 |
SM
Senvest Management
New York
|
-$513K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$159K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$130K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFG
76
Next Financial Group
Houston,
Texas
| $5K | – | – | – |
|
|
DADC
77
D.A. Davidson & Co
Great Falls,
Montana
| $4K | – | – | – |
|
78
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
79
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
BFM
80
Boothbay Fund Management
New York
| $237 | +$221K | +28,249 | New |
|
|
GIM
81
Granahan Investment Management
Waltham,
Massachusetts
| – | -$1.31M | -183,382 | Closed |
|
|
82
Wolverine Trading
Chicago,
Illinois
| – | -$130K | -16,650 | Closed |
|
|
AG
83
Advisor Group
Phoenix,
Arizona
| – | -$9K | -1,270 | Closed |
|
ELOS Hedge Fund Activity: Q4 2016 in Review
80 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q4 2016, worth a combined $199M — up 22% from $163M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new ELOS positions and 4 closed out — a net gain of 16 holders — while 32 added to existing stakes and 9 trimmed.
The largest buyer was HealthInvest Partners, opening a new position worth an estimated $5.53M. The largest seller was Royce & Associates, cutting an estimated $2.75M.
- 80 institutional investors held Syneron Medical Ltd (ELOS) as of Q4 2016, up from 65 in Q3 2016.
- Funds reported $199M of Syneron Medical Ltd stock for Q4 2016, up 22% quarter-over-quarter.
- 20 funds opened new Syneron Medical Ltd positions in Q4 2016 and 4 closed out, a net change of +16 holders.
- The largest Syneron Medical Ltd buyer in Q4 2016 was HealthInvest Partners, an estimated $5.53M added.
- The largest Syneron Medical Ltd seller in Q4 2016 was Royce & Associates, an estimated $2.75M sold.
Based on aggregated 13F filings for Q4 2016.